Request the Commissioner of Food and Drugs to take urgent action concerning the off-label use of GnRH agonists, a class of drugs also known as Puberty Blockers in Children.
🏛 Food and Drug Administration (FDA)FDA-2023-P-3767
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.